Floatz logo

Cilostazol

Cerebrovascular Disorder

Zhejiang Provincial People's HospitalUNKNOWNPhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Cerebrovascular Disorder cohort.

Asset / SponsorPhaseRating
WARFARIN
Seoul National University Hospital
Phase 4BBB
Aspirin
Peking Union Medical College Hospital
Phase 3BB
ATORVASTATIN
Sichuan Provincial People's Hospital
Phase 4BB
Tenecteplase
University of Melbourne
Phase 3BB
CLOPIDOGREL
Peking Union Medical College Hospital
Phase 3BB

View all 34 →

Same molecule, other indications

Cilostazol is also rated in:

cerebral infarctionActive
BBB
Indicative · Phase 4
79 / 100
View asset →
transient ischemic attackActive
BBB
Indicative · Phase 4
75 / 100
View asset →
ischemic strokeActive
BBB
Indicative · Phase 4
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →